Cancer Care Ontario | Action Cancer Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

41 Results

Guidelines and Advice

Safety Considerations for the Implementation of Subcutaneous Rituximab Formulation

Status: Current
Version: 1

Dec 1969

Guidelines and Advice

Self-Management in Cancer: Quality Standards

Status: Current
ID: N/A
Version: 1

Nov 2018

Guidelines and Advice

Systemic therapy of denosumab in altering surgical outcomes in patients with giant cell tumour of bone

Status: Current
ID: ES 11-13

Dec 1969

Guidelines and Advice

Systemic Therapy for Metastatic Urothelial Cancer: An Endorsement of a Portion of the European Association of Urology Guideline on Muscle-Invasive and Metastatic Bladder Cancer

Status: In-Review
ID: GL END 3-24

Dec 1969

Guidelines and Advice

Systemic Treatment Emergency Preparedness Guidance Document

Status: Current

Dec 1969

Pages